Table 3.
Comparison of end-tidal desflurane concentration and BIS between patients with MELD <20 and MELD ≥20
| MELD <20 (n=26) |
MELD ≥20 (n=14) |
P | |
|---|---|---|---|
| Baseline | |||
| Et-Des | - | - | - |
| BIS | 95.85±1.69 | 96.86±1.61 | 0.07 |
| Time Duration (min) | - | - | - |
| Dissection phase | |||
| Et-Des | 3.11±0.49% | 2.58±0.77% | 0.01 |
| BIS | 50.54±3.86 | 52.14±8.70 | 0.02 |
| Time Duration (min) | 298.42±76.01 | 319.93±113.70 | 0.48 |
| Anhepatic phase | |||
| Et-Des | 2.96±0.76% | 2.17±0.79% | 0.003 |
| BIS | 45.09±3.94 | 44.86±5.30 | 0.32 |
| Time Duration (min) | 195.23±43.56 | 211.14±40.81 | 0.26 |
| Neohepatic phase | |||
| Et-Des | 2.72±0.57% | 2.32±0.87% | 0.07 |
| BIS | 45.93±3.67 | 45.37±4.93 | 0.27 |
| Time Duration (min) | 175.27±40.63 | 171.64±55.49 | 0.81 |
MELD – Model for End -stage Liver Disease; Et-Des – End-tidal desflurane concentration, Values expressed as mean±S.D, P<0.05 significant